Ikarian Capital »

Cue Biopharma shares owned by Ikarian Capital

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.3M 104k 31.56

More positions owned by Ikarian Capital

Abivax Sa Sponsored Ads (ABVX)
Ionis Pharmaceuticals Call Option (IONS)
Kodiak Sciences (KOD)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Alumis (ALMS)
Praxis Precision Medicines I Com New (PRAX)
Moderna Put Option (MRNA)
Capricor Therapeutics Com New (CAPR)
Vaxcyte (PCVX)
Biosante Pharmaceuticals (ANIP)
Celldex Therapeutics Com New (CLDX)
Tenax Therapeutics Com New (TENX)
Vera Therapeutics Cl A (VERA)
Arcus Biosciences Incorporated (RCUS)
Relmada Therapeutics (RLMD)

View all positions for Ikarian Capital

Top funds holding Cue Biopharma

Bleichroeder
Vanguard Capital Management
Ikarian Capital
ADAR1 Capital Management
Lion Point Capital
Squadron Capital Management
Belvedere Trading
Citadel Advisors
Vanguard Fiduciary Trust
Texas Capital Bank Wealth Management Services
Renaissance Technologies
Robertson Stephens Wealth Management
Advisory Research
Stifel Financial
Angeles Wealth Management

View all funds holding Cue Biopharma